-
1
-
-
84866732231
-
ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The task force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC)
-
P.G. Steg, S.K. James, and D. Atar ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC) Eur Heart J 33 2012 2569 2619
-
(2012)
Eur Heart J
, vol.33
, pp. 2569-2619
-
-
Steg, P.G.1
James, S.K.2
Atar, D.3
-
2
-
-
84872698656
-
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. American College of Emergency Physicians; Society for Cardiovascular Angiography and Interventions
-
P.T. O'Gara, F.G. Kushner, and D.D. Ascheim 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. American College of Emergency Physicians; Society for Cardiovascular Angiography and Interventions J Am Coll Cardiol 61 2013 e78 e140
-
(2013)
J Am Coll Cardiol
, vol.61
, pp. e78-e140
-
-
O'Gara, P.T.1
Kushner, F.G.2
Ascheim, D.D.3
-
3
-
-
37849002889
-
12 receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease
-
12 receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease Eur Heart J 29 2008 21 30
-
(2008)
Eur Heart J
, vol.29
, pp. 21-30
-
-
Wallentin, L.1
Varenhorst, C.2
James, S.3
-
4
-
-
73949112820
-
Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: The ONSET/OFFSET study
-
P.A. Gurbel, K.P. Bliden, and K. Butler Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study Circulation 120 2009 2577 2585
-
(2009)
Circulation
, vol.120
, pp. 2577-2585
-
-
Gurbel, P.A.1
Bliden, K.P.2
Butler, K.3
-
5
-
-
49249137412
-
Impaired bioavailability of clopidogrel in patients with a ST-segment elevation myocardial infarction
-
A.A. Heestermans, J.W. van Werkum, and D. Taubert Impaired bioavailability of clopidogrel in patients with a ST-segment elevation myocardial infarction Thromb Res 122 2008 776 781
-
(2008)
Thromb Res
, vol.122
, pp. 776-781
-
-
Heestermans, A.A.1
Van Werkum, J.W.2
Taubert, D.3
-
6
-
-
84867995439
-
Prasugrel versus high dose clopidogrel to overcome early high on clopidogrel platelet reactivity in patients with ST elevation myocardial infarction
-
D. Alexopoulos, K.C. Theodoropoulos, and E.F. Stavrou Prasugrel versus high dose clopidogrel to overcome early high on clopidogrel platelet reactivity in patients with ST elevation myocardial infarction Cardiovasc Drugs Ther 26 2012 393 400
-
(2012)
Cardiovasc Drugs Ther
, vol.26
, pp. 393-400
-
-
Alexopoulos, D.1
Theodoropoulos, K.C.2
Stavrou, E.F.3
-
7
-
-
84873020765
-
Effects of pre-hospital clopidogrel administration on early and late residual platelet reactivity in ST-segment elevation myocardial infarction patients undergoing primary intervention
-
S. Biscaglia, M. Tebaldi, and P. Vranckx Effects of pre-hospital clopidogrel administration on early and late residual platelet reactivity in ST-segment elevation myocardial infarction patients undergoing primary intervention J Thromb Haemost 11 2013 192 194
-
(2013)
J Thromb Haemost
, vol.11
, pp. 192-194
-
-
Biscaglia, S.1
Tebaldi, M.2
Vranckx, P.3
-
8
-
-
84858760413
-
Prasugrel versus tirofiban bolus with or without short post-bolus infusion with or without concomitant prasugrel administration in patients with myocardial infarction undergoing coronary stenting: The FABOLUS PRO
-
Facilitation through Aggrastat by drOpping or shortening Infusion Line in patients with STsegment elevation myocardial infarction compared to or on top of PRasugrel given at loading dOse) tria
-
M. Valgimigli, M. Tebaldi, and G. Campo Prasugrel versus tirofiban bolus with or without short post-bolus infusion with or without concomitant prasugrel administration in patients with myocardial infarction undergoing coronary stenting: the FABOLUS PRO (Facilitation through Aggrastat By drOpping or shortening Infusion Line in patients with STsegment elevation myocardial infarction compared to or on top of PRasugrel given at loading dOse) trial J Am Coll Cardiol Intv 5 2012 268 277
-
(2012)
J Am Coll Cardiol Intv
, vol.5
, pp. 268-277
-
-
Valgimigli, M.1
Tebaldi, M.2
Campo, G.3
-
9
-
-
84873530056
-
Randomized assessment of ticagrelor versus prasugrel antiplatelet effects in patients with ST-segment-elevation myocardial infarction
-
D. Alexopoulos, I. Xanthopoulou, and V. Gkizas Randomized assessment of ticagrelor versus prasugrel antiplatelet effects in patients with ST-segment-elevation myocardial infarction Circ Cardiovasc Interv 5 2012 797 804
-
(2012)
Circ Cardiovasc Interv
, vol.5
, pp. 797-804
-
-
Alexopoulos, D.1
Xanthopoulou, I.2
Gkizas, V.3
-
10
-
-
84875997213
-
Comparison of prasugrel and ticagrelor loading doses in ST-segment elevation myocardial infarction patients: RAPID (Rapid Activity of Platelet Inhibitor Drugs) primary PCI study
-
G. Parodi, R. Valenti, and B. Bellandi Comparison of prasugrel and ticagrelor loading doses in ST-segment elevation myocardial infarction patients: RAPID (Rapid Activity of Platelet Inhibitor Drugs) primary PCI study J Am Coll Cardiol 61 2013 1601 1606
-
(2013)
J Am Coll Cardiol
, vol.61
, pp. 1601-1606
-
-
Parodi, G.1
Valenti, R.2
Bellandi, B.3
-
11
-
-
84880179194
-
Antiplatelet therapy: Does prasugrel or ticagrelor suffice in patients with STEMI?
-
K. Agrawal, and D.L. Bhatt Antiplatelet therapy: does prasugrel or ticagrelor suffice in patients with STEMI? Nat Rev Cardiol 10 2013 121 122
-
(2013)
Nat Rev Cardiol
, vol.10
, pp. 121-122
-
-
Agrawal, K.1
Bhatt, D.L.2
-
12
-
-
84896694643
-
Morphine decreases clopidogrel concentrations and effects: A randomized, double-blind, placebo-controlled trial
-
E.L. Hobl, T. Stimpfl, and J. Ebner Morphine decreases clopidogrel concentrations and effects: a randomized, double-blind, placebo-controlled trial J Am Coll Cardiol 63 2014 630 635
-
(2014)
J Am Coll Cardiol
, vol.63
, pp. 630-635
-
-
Hobl, E.L.1
Stimpfl, T.2
Ebner, J.3
-
13
-
-
84927768608
-
Morphine is associated with a delayed activity of oral antiplatelet agents in patients with ST-elevation acute myocardial infarction undergoing primary percutaneous coronary intervention
-
[pii: e001593]
-
G. Parodi, B. Bellandi, and I. Xanthopoulou Morphine is associated with a delayed activity of oral antiplatelet agents in patients with ST-elevation acute myocardial infarction undergoing primary percutaneous coronary intervention Circ Cardiovasc Interv 8 1 2014 10.1161/CIRCINTERVENTIONS.114.001593 [pii: e001593]
-
(2014)
Circ Cardiovasc Interv
, vol.8
, Issue.1
-
-
Parodi, G.1
Bellandi, B.2
Xanthopoulou, I.3
-
14
-
-
84922391666
-
Prehospital ticagrelor in ST-segment elevation myocardial infarction
-
G. Montalescot, A.W. van 't Hof, and F. Lapostolle Prehospital ticagrelor in ST-segment elevation myocardial infarction N Engl J Med 371 2014 1016 1027
-
(2014)
N Engl J Med
, vol.371
, pp. 1016-1027
-
-
Montalescot, G.1
Van 'T Hof, A.W.2
Lapostolle, F.3
-
15
-
-
60649112469
-
Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITONTIMI 38): Double-blind, randomised controlled trial
-
G. Montalescot, S.D. Wiviott, and E. Braunwald Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITONTIMI 38): double-blind, randomised controlled trial Lancet 373 2009 723 731
-
(2009)
Lancet
, vol.373
, pp. 723-731
-
-
Montalescot, G.1
Wiviott, S.D.2
Braunwald, E.3
-
16
-
-
43749117048
-
Early and late benefits of prasugrel in patients with acute coronary syndromes undergoing percutaneous coronary intervention: A TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thrombolysis in Myocardial Infarction) analysis
-
E.M. Antman, S.D. Wiviott, and S.A. Murphy Early and late benefits of prasugrel in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thrombolysis In Myocardial Infarction) analysis J Am Coll Cardiol 51 2008 2028 2033
-
(2008)
J Am Coll Cardiol
, vol.51
, pp. 2028-2033
-
-
Antman, E.M.1
Wiviott, S.D.2
Murphy, S.A.3
-
17
-
-
78650174722
-
Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: A Platelet Inhibition and Patient Outcomes (PLATO) trial subgroup analysis
-
P.G. Steg, S. James, and R.A. Harrington Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: a Platelet Inhibition and Patient Outcomes (PLATO) trial subgroup analysis Circulation 122 2010 2131 2141
-
(2010)
Circulation
, vol.122
, pp. 2131-2141
-
-
Steg, P.G.1
James, S.2
Harrington, R.A.3
-
18
-
-
84883624073
-
Stent thrombosis with ticagrelor versus clopidogrel in patients with acute coronary syndromes: An analysis from the prospective randomized PLATO trial
-
P.G. Steg, R.A. Harrington, and H. Emanuelsson Stent thrombosis with ticagrelor versus clopidogrel in patients with acute coronary syndromes: an analysis from the prospective randomized PLATO trial Circulation 128 2013 1055 1065
-
(2013)
Circulation
, vol.128
, pp. 1055-1065
-
-
Steg, P.G.1
Harrington, R.A.2
Emanuelsson, H.3
-
20
-
-
84856441795
-
ST-elevation acute coronary syndromes in the Platelet Inhibition and Patient Outcomes (PLATO) trial: Insights from the ECG substudy
-
P.W. Armstrong, H. Siha, and Y. Fu ST-elevation acute coronary syndromes in the Platelet Inhibition and Patient Outcomes (PLATO) trial: insights from the ECG substudy Circulation 125 2012 514 521
-
(2012)
Circulation
, vol.125
, pp. 514-521
-
-
Armstrong, P.W.1
Siha, H.2
Fu, Y.3
-
21
-
-
84880277927
-
Angiographic outcomes in the PLATO trial (Platelet Inhibition and Patient Outcomes)
-
V. Kunadian, S.K. James, and D.M. Wojdyla Angiographic outcomes in the PLATO trial (Platelet Inhibition and Patient Outcomes) JACC Cardiovasc Interv 6 2013 671 683
-
(2013)
JACC Cardiovasc Interv
, vol.6
, pp. 671-683
-
-
Kunadian, V.1
James, S.K.2
Wojdyla, D.M.3
-
22
-
-
84860840005
-
Efficacy and safety of a high loading dose of clopidogrel administered prehospitally to improve primary percutaneous coronary intervention in acute myocardial infarction: The randomized CIPAMI trial
-
U. Zeymer, H.R. Arntz, and B. Mark Efficacy and safety of a high loading dose of clopidogrel administered prehospitally to improve primary percutaneous coronary intervention in acute myocardial infarction: the randomized CIPAMI trial Clin Res Cardiol 101 2012 305 312
-
(2012)
Clin Res Cardiol
, vol.101
, pp. 305-312
-
-
Zeymer, U.1
Arntz, H.R.2
Mark, B.3
-
23
-
-
82955194859
-
Effect of upstream clopidogrel treatment in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
-
S. Koul, J.G. Smith, and F. Schersten Effect of upstream clopidogrel treatment in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention Eur Heart J 32 2011 2989 2997
-
(2011)
Eur Heart J
, vol.32
, pp. 2989-2997
-
-
Koul, S.1
Smith, J.G.2
Schersten, F.3
-
24
-
-
82955201639
-
Clopidogrel pre-treatment is associated with reduced in-hospital mortality in primary percutaneous coronary intervention for acute ST-elevation myocardial infarction
-
J. Dorler, M. Edlinger, and H.F. Alber Clopidogrel pre-treatment is associated with reduced in-hospital mortality in primary percutaneous coronary intervention for acute ST-elevation myocardial infarction Eur Heart J 32 2011 2954 2961
-
(2011)
Eur Heart J
, vol.32
, pp. 2954-2961
-
-
Dorler, J.1
Edlinger, M.2
Alber, H.F.3
-
25
-
-
84883211765
-
Double vs standard loading dose of ticagrelor: Onset of antiplatelet action in patients with STEMI undergoing primary PCI
-
D. Alexopoulos, V. Gkizas, and S. Patsilinakos Double vs standard loading dose of ticagrelor: onset of antiplatelet action in patients with STEMI undergoing primary PCI J Am Coll Cardiol 62 2013 940 941
-
(2013)
J Am Coll Cardiol
, vol.62
, pp. 940-941
-
-
Alexopoulos, D.1
Gkizas, V.2
Patsilinakos, S.3
-
26
-
-
84901757847
-
Comparison of double (360 mg) ticagrelor loading dose with standard (60 mg) prasugrel loading dose in ST-elevation myocardial infarction patients: The Rapid Activity of Platelet Inhibitor Drugs (RAPID) primary PCI 2 study
-
G. Parodi, B. Bellandi, and R. Valenti Comparison of double (360 mg) ticagrelor loading dose with standard (60 mg) prasugrel loading dose in ST-elevation myocardial infarction patients: The Rapid Activity of Platelet Inhibitor Drugs (RAPID) primary PCI 2 study Am Heart J 167 2014 909 914
-
(2014)
Am Heart J
, vol.167
, pp. 909-914
-
-
Parodi, G.1
Bellandi, B.2
Valenti, R.3
-
27
-
-
84900448436
-
Onset of antiplatelet action with high (100 mg) versus standard (60 mg) loading dose of prasugrel in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: Pharmacodynamic study
-
D. Alexopoulos, G. Makris, and I. Xanthopoulou Onset of antiplatelet action with high (100 mg) versus standard (60 mg) loading dose of prasugrel in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: pharmacodynamic study Circ Cardiovasc Interv 7 2014 233 239
-
(2014)
Circ Cardiovasc Interv
, vol.7
, pp. 233-239
-
-
Alexopoulos, D.1
Makris, G.2
Xanthopoulou, I.3
-
28
-
-
84879733565
-
Evaluation of crushed ticagrelor tablet doses: Recovery following crushing and naso-gastric tube passage ex vivo
-
B. Crean, C. Finnie, and A. Crosby Evaluation of crushed ticagrelor tablet doses: recovery following crushing and naso-gastric tube passage ex vivo Drugs R D 13 2013 153 157
-
(2013)
Drugs R D
, vol.13
, pp. 153-157
-
-
Crean, B.1
Finnie, C.2
Crosby, A.3
-
29
-
-
84922328786
-
Ticagrelor crushed tablets administration in STEMI patients: The MOJITO study
-
G. Parodi, I. Xanthopoulou, and B. Bellandi Ticagrelor crushed tablets administration in STEMI patients: the MOJITO study J Am Coll Cardiol 65 2015 511 512
-
(2015)
J Am Coll Cardiol
, vol.65
, pp. 511-512
-
-
Parodi, G.1
Xanthopoulou, I.2
Bellandi, B.3
-
31
-
-
84862772806
-
Pharmacodynamic effects of cangrelor and clopidogrel: The platelet function substudy from the cangrelor versus standard therapy to achieve optimal management of platelet inhibition (CHAMPION) trials
-
D.J. Angiolillo, D.J. Schneider, and D.L. Bhatt Pharmacodynamic effects of cangrelor and clopidogrel: the platelet function substudy from the cangrelor versus standard therapy to achieve optimal management of platelet inhibition (CHAMPION) trials J Thromb Thrombolysis 34 2012 44 55
-
(2012)
J Thromb Thrombolysis
, vol.34
, pp. 44-55
-
-
Angiolillo, D.J.1
Schneider, D.J.2
Bhatt, D.L.3
-
32
-
-
84875779761
-
Effect of platelet inhibition with cangrelor during PCI on ischemic events
-
D.L. Bhatt, G.W. Stone, and K.W. Mahaffey Effect of platelet inhibition with cangrelor during PCI on ischemic events N Engl J Med 368 2013 1303 1313
-
(2013)
N Engl J Med
, vol.368
, pp. 1303-1313
-
-
Bhatt, D.L.1
Stone, G.W.2
Mahaffey, K.W.3
-
33
-
-
84890136652
-
Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: A pooled analysis of patient-level data
-
P.G. Steg, D.L. Bhatt, and C.W. Hamm Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: a pooled analysis of patient-level data Lancet 382 2013 1981 1992
-
(2013)
Lancet
, vol.382
, pp. 1981-1992
-
-
Steg, P.G.1
Bhatt, D.L.2
Hamm, C.W.3
-
34
-
-
84896691558
-
Impact of intraprocedural stent thrombosis during percutaneous coronary intervention: Insights from the CHAMPION PHOENIX Trial (Clinical Trial Comparing Cangrelor to Clopidogrel Standard of Care Therapy in Subjects Who Require Percutaneous Coronary Intervention)
-
P. Généreux, G.W. Stone, and R.A. Harrington Impact of intraprocedural stent thrombosis during percutaneous coronary intervention: insights from the CHAMPION PHOENIX Trial (Clinical Trial Comparing Cangrelor to Clopidogrel Standard of Care Therapy in Subjects Who Require Percutaneous Coronary Intervention) J Am Coll Cardiol 63 2014 619 629
-
(2014)
J Am Coll Cardiol
, vol.63
, pp. 619-629
-
-
Généreux, P.1
Stone, G.W.2
Harrington, R.A.3
-
35
-
-
0032485876
-
Pharmacodynamic profile of short-term abciximab treatment demonstrates prolonged platelet inhibition with gradual recovery from GP IIb/IIIa receptor blockade
-
M.A. Mascelli, E.T. Lance, and L. Damaraju Pharmacodynamic profile of short-term abciximab treatment demonstrates prolonged platelet inhibition with gradual recovery from GP IIb/IIIa receptor blockade Circulation 97 1998 1680 1688
-
(1998)
Circulation
, vol.97
, pp. 1680-1688
-
-
Mascelli, M.A.1
Lance, E.T.2
Damaraju, L.3
-
36
-
-
0027379391
-
MK-383 (L-700,462), a selective nonpeptide platelet glycoprotein IIb/IIIa antagonist, is active in man
-
K. Peerlinck, I. De Lepeleire, and M. Goldberg MK-383 (L-700,462), a selective nonpeptide platelet glycoprotein IIb/IIIa antagonist, is active in man Circulation 88 1993 1512 1517
-
(1993)
Circulation
, vol.88
, pp. 1512-1517
-
-
Peerlinck, K.1
De Lepeleire, I.2
Goldberg, M.3
-
37
-
-
16944362255
-
Combined accelerated tissue-plasminogen activator and platelet glycoprotein IIb/IIIa integrin receptor blockade with integrilin in acute myocardial infarction: Results of a randomized, placebo-controlled, dose-ranging trial
-
E.M. Ohman, N.S. Kleiman, and G. Gacioch Combined accelerated tissue-plasminogen activator and platelet glycoprotein IIb/IIIa integrin receptor blockade with integrilin in acute myocardial infarction: results of a randomized, placebo-controlled, dose-ranging trial Circulation 95 1997 846 854
-
(1997)
Circulation
, vol.95
, pp. 846-854
-
-
Ohman, E.M.1
Kleiman, N.S.2
Gacioch, G.3
-
39
-
-
84898460060
-
High rates of prasugrel and ticagrelor non-responder in patients treated with therapeutic hypothermia after cardiac arrest
-
K. Ibrahim, M. Christoph, and S. Schmeinck High rates of prasugrel and ticagrelor non-responder in patients treated with therapeutic hypothermia after cardiac arrest Resuscitation 85 2014 649 656
-
(2014)
Resuscitation
, vol.85
, pp. 649-656
-
-
Ibrahim, K.1
Christoph, M.2
Schmeinck, S.3
-
40
-
-
16444368352
-
Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: A meta-analysis of randomized trials
-
G. De Luca, H. Suryapranata, and G.W. Stone Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials JAMA 293 2005 1759 1765
-
(2005)
JAMA
, vol.293
, pp. 1759-1765
-
-
De Luca, G.1
Suryapranata, H.2
Stone, G.W.3
-
41
-
-
2342428087
-
Improved clinical outcomes with abciximab therapy in acute myocardial infarction: A systematic overview of randomized clinical trials
-
D.E. Kandzari, V. Hasselblad, and J.E. Tcheng Improved clinical outcomes with abciximab therapy in acute myocardial infarction: a systematic overview of randomized clinical trials Am Heart J 147 2004 457 462
-
(2004)
Am Heart J
, vol.147
, pp. 457-462
-
-
Kandzari, D.E.1
Hasselblad, V.2
Tcheng, J.E.3
-
42
-
-
44249120546
-
Facilitated PCI in patients with ST-elevation myocardial infarction
-
S.G. Ellis, M. Tendera, and M.A. de Belder Facilitated PCI in patients with ST-elevation myocardial infarction N Engl J Med 358 2008 2205 2217
-
(2008)
N Engl J Med
, vol.358
, pp. 2205-2217
-
-
Ellis, S.G.1
Tendera, M.2
De Belder, M.A.3
-
43
-
-
49149128492
-
Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): A multicentre, double-blind, randomised controlled trial
-
A.W. Van't Hof, J. Ten Berg, and T. Heestermans Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomised controlled trial Lancet 372 2008 537 546
-
(2008)
Lancet
, vol.372
, pp. 537-546
-
-
Van'T Hof, A.W.1
Ten Berg, J.2
Heestermans, T.3
-
44
-
-
84859110711
-
Prehospital abciximab in ST-segment elevation myocardial infarction: Results of the randomized, double-blind MISTRAL study
-
P. Ohlmann, P. Reydel, and L. Jacquemin Prehospital abciximab in ST-segment elevation myocardial infarction: results of the randomized, double-blind MISTRAL study Circ Cardiovasc Interv 5 2012 69 76
-
(2012)
Circ Cardiovasc Interv
, vol.5
, pp. 69-76
-
-
Ohlmann, P.1
Reydel, P.2
Jacquemin, L.3
-
45
-
-
44249122195
-
Bivalirudin during primary PCI in acute myocardial infarction
-
G.W. Stone, B. Witzenbichler, and G. Guagliumi Bivalirudin during primary PCI in acute myocardial infarction N Engl J Med 358 2008 2218 2230
-
(2008)
N Engl J Med
, vol.358
, pp. 2218-2230
-
-
Stone, G.W.1
Witzenbichler, B.2
Guagliumi, G.3
-
46
-
-
78349308635
-
Prehospital triple antiplatelet therapy in patients with acute ST elevation myocardial infarction leads to better platelet aggregation inhibition and clinical outcome than dual antiplatelet therapy
-
J.J. Smit, J.W. van Werkum, and J. ten Berg Prehospital triple antiplatelet therapy in patients with acute ST elevation myocardial infarction leads to better platelet aggregation inhibition and clinical outcome than dual antiplatelet therapy Heart 96 2010 1815 1820
-
(2010)
Heart
, vol.96
, pp. 1815-1820
-
-
Smit, J.J.1
Van Werkum, J.W.2
Ten Berg, J.3
-
47
-
-
84889260178
-
Bivalirudin started during emergency transport for primary PCI
-
P.G. Steg, A. van 't Hof, and C.W. Hamm Bivalirudin started during emergency transport for primary PCI N Engl J Med 369 2013 2207 2217
-
(2013)
N Engl J Med
, vol.369
, pp. 2207-2217
-
-
Steg, P.G.1
Van 'T Hof, A.2
Hamm, C.W.3
-
48
-
-
84925348111
-
Unfractionated heparin versus bivalirudin in primary percutaneous coronary intervention (HEAT-PPCI): An open-label, single centre, randomised controlled trial
-
A. Shahzad, I. Kemp, and C. Mars Unfractionated heparin versus bivalirudin in primary percutaneous coronary intervention (HEAT-PPCI): an open-label, single centre, randomised controlled trial Lancet 384 2014 1849 1858
-
(2014)
Lancet
, vol.384
, pp. 1849-1858
-
-
Shahzad, A.1
Kemp, I.2
Mars, C.3
-
49
-
-
84921374025
-
Acute stent thrombosis after primary percutaneous coronary intervention: Insights from the EUROMAX Trial (European Ambulance Acute Coronary Syndrome Angiography)
-
P. Clemmensen, S. Wiberg, and A. Van't Hof Acute stent thrombosis after primary percutaneous coronary intervention: insights from the EUROMAX Trial (European Ambulance Acute Coronary Syndrome Angiography) JACC Cardiovasc Interv 8 2015 214 220
-
(2015)
JACC Cardiovasc Interv
, vol.8
, pp. 214-220
-
-
Clemmensen, P.1
Wiberg, S.2
Van'T Hof, A.3
-
50
-
-
84927551392
-
Bivalirudin vs heparin with or without tirofiban during primary percutaneous coronary intervention in acute myocardial infarction: The BRIGHT randomized clinical trial
-
Y. Han, J. Guo, and Y. Zheng Bivalirudin vs heparin with or without tirofiban during primary percutaneous coronary intervention in acute myocardial infarction: the BRIGHT randomized clinical trial JAMA 313 2015 1336 1346
-
(2015)
JAMA
, vol.313
, pp. 1336-1346
-
-
Han, Y.1
Guo, J.2
Zheng, Y.3
|